Zehua Wu

Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer

Jianxia Li, Cheng Wu, Huabin Hu et al. · Cancer Cell · 2023 · 339 citations · Full text

Medicine, Immunology, Oncology +16

Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial

Huabin Hu, Liang Kang, Jianwei Zhang et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 296 citations

Medicine, Oncology, Immunotherapy +15

Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer

Zehua Wu, Xiaoliang Wang, Huamei Tang et al. · Oncology Reports · 2014 · 212 citations · Full text

Medicine, Molecular Biology, Oncology +13

Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial

Huabin Hu, Jianwei Zhang, Yunfeng Li et al. · Journal of Clinical Oncology · 2024 · 63 citations

Medicine, Oncology, Surgery +17

Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with <i>RAS</i>/<i>BRAF</i> Wild-Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II Trial

Huabin Hu, Kun Wang, Meijin Huang et al. · The Oncologist · 2020 · 50 citations · Full text

Medicine, Oncology, Pharmacotherapy +15